MYB and leukemia: Hence, Myb knockdown in leukaemia cells with wild-type or Cter/Nter–mutant C/EBPα resulted in the loss of a leukaemia stem cell signature and the up-regulation of a gene expression pattern generally observed in patients that are responding to therapeutic treatment.